New frontiers in nonhormonal male contraception

Contraception

Volumn 82, Issue 5, 2010, Pages 476-482

  Cheng, C Yan ^a   Mruk, Dolores D ^a  

^a POPULATION COUNCIL   (United States)

Author keywords

Adjudin; Cell adhesion; Male contraceptive; Spermatogenesis; Testis

Indexed keywords

ADJUDIN; AF 2785; CALCIUM CHANNEL BLOCKING AGENT; GAMENDAZOLE; INDENOPYRIDINE DERIVATIVE; LONIDAMINE; PYRIDINE DERIVATIVE; TESTOSTERONE; UNCLASSIFIED DRUG; VACCINE;

BIRTH CONTROL; HORMONAL CONTRACEPTION; HUMAN; HYPOPHYSIS; HYPOTHALAMUS; MALE FERTILITY; NONHUMAN; PRACTICE GUIDELINE; REVIEW; SEMEN ANALYSIS; TESTIS;

ANIMALS; ANTISPERMATOGENIC AGENTS; CONTRACEPTION; CONTRACEPTIVE AGENTS, MALE; FAMILY PLANNING SERVICES; HUMANS; MALE; VACCINES, CONTRACEPTIVE;

EID: 77957752496     PISSN: 00107824     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.contraception.2010.03.017     Document Type: Review

References (87)

1. Martin C.W., Anderson R.A., and Cheng L. Potential impact of hormonal male contraception: cross-cultural implications for development of novel preparations Hum Reprod 15 2000 637 645
2. Eberhardt J., van Wersch A., and Meikle N. Attitudes towards the male contraceptive pill in men and women in casual and stable sexual relationships J Fam Plann Health Reprod Care 35 2009 161 165
3. Goldacre M.J., Wotton C.J., Seagroatt V., and Yeates D. Immune-related disease before and after vasectomy: an epidemiological database study Hum Reprod 22 2007 1273 1278
4. Massey F.J., Berstein G.S., and O'Fallon W.M. Vasectomy and health. Results from a large cohort study JAMA 252 1984 1023 1029
5. Kohler T.S., Fazili A.A., and Brannigan R.E. Putative health risks associated with vasectomy Urol Clin North Am 36 2009 337 345
6. Trussell J. Contraceptive failure in the United States Contraception 70 2004 89 96
7. Gu Y.Q., Liang X., and Wu W. Multicenter contraceptive efficacy trial of injectable testosterone undecanoate in Chinese men J Clin Endocrinol Metab 94 2009 1910 1915
8. Handelsman D.J., Farley T.M., Peregoudov A., and Waites G.M. Factors in nonuniform induction of azoospermia by testosterone enanthate in normal men. World Health Organization Task Force on Methods for the Regulation of Male Fertility Fertil Steril 63 1995 125 133
9. Hay C.J., Brady B.M., and Zitmann M. A multicenter Phase IIb study of a novel combination on intramuscular androgen (testosterone decanoate) and oral progestogen (etonogestrel) for male hormonal contraception J Clin Endocrinol Metab 90 2005 2042 2049
10. Cheng C.Y., Silvestrini B., and Grima J. Two new male contraceptives exert their effects by depleting germ cells prematurely from the testis Biol Reprod 65 2001 449 461
11. Grima J., Silvestrini B., and Cheng C.Y. Reversible inhibition of spermatogenesis in rats using a new male contraceptive, 1-(2,4-dichlorobenzyl)- indazole-3-carbohydrazide Biol Reprod 64 2001 1500 1508
12. Cheng C.Y., Mruk D., and Silvestrini B. AF-2364 [1-(2,4-dichlorobenzyl)- 1H-indazole-3-carbohydrazide] is a potential male contraceptive: a review of recent data Contraception 72 2005 251 261
13. Mruk D.D., Wong C.H., Silvestrini B., and Cheng C.Y. A male contraceptive targeting germ cell adhesion Nat Med 12 2006 1323 1328
14. Hu G.X., Hu L.F., and Yang D.Z. Adjudin targeting rabbit germ cell adhesion as a male contraceptive: a pharmacokinetic study J Androl 30 2008 87 93
15. Lohiya N.K., Manivannan B., and Mishra P.K. Ultrastructural changes in the spermatozoa of langur monkeys Presbytis entellus after vas occlusion with styrene maleic anhydride Contraception 57 1998 125 132
16. Lohiya N.K., Suthar R., and Khandelwal A. Sperm characteristics and teratology in rats following vas deferens occlusion with RISUG and its reversal Int J Androl 2009 10.1111/j.1365-2605.2009.00992.x
17. Koul V., Srivastava A., and Guha S.K. Reversibility with sodium bicarbonate of styrene maleic anhydride, an intravasal injectable contraceptive, in male rats Contraception 58 1998 227 231
18. Manivannan B., Mishra P.K., and Lohiya N.K. Ultrastructural changes in the vas deferens of langur monkeys Presbytis entellus entellus after vas occlusion with styrene maleic anhydride and after its reversal Contraception 59 1999 137 144
19. Jha R.K., Jha P.K., and Guha S.K. Smart RISUG: a potential new contraceptive and its magnetic field-mediated sperm interaction Int J Nanomed 4 2009 55 64
20. Zhang Y., Kohler N., and Zhang M. Surface modification of superparamagnetic magnetite nanoparticles and their intracellular uptake Biomaterials 23 2002 1553 1561
21. Roblero L., Guadarrama A., Lopez T., and Zegers-Hochschild F. Effect of copper ion on the motility, viability, acrosome reaction and fertilizing capacity of human spermatozoa in vitro Reprod Fertil Dev 8 1996 871 874
22. Guha S.K., Singh G., and Ansari S. Phase II clinical trial of a vas deferens injectable contraceptive for the male Contraception 56 1997 245 250
23. Guha S.K., Singh G., and Anand S. Phase I clinical trial of an injectable contraceptive for the male Contraception 48 1993 367 375
24. Sharma R.S., Rajanna A., Singh B.K., Mathur A.K., and Mukherjee A.K. Current status of development of RISUG: an intravasal injectable male contraceptive R.S. Sharma, A. Rajanna, M. Rajalakshmi, Proceedings of the Conference on Recent Advances and Challenges in Reproductive Health Research 2007 Indian Society for the Study of Reproduction and Fertility New Delhi, India 127 140
25. Naz R.K., Gupta S.K., Gupta J.C., Vyas H.K., and Talwar G.P. Recent advances in contraceptive vaccine development: a mini-review Hum Reprod 20 2005 3271 3283
26. Aitken R.J. Immunocontraceptive vaccines for human use J Reprod Immunol 57 2002 273 287
27. Frayne J., and Hall L. The potential use of sperm antigens as targets for immunocontraception; past, present and future J Reprod Immunol 43 1999 1 33
28. Anderson R.A., and Baird D.T. Male contraception Endocr Rev 23 2002 735 762
29. Suri A. Family of sperm associated antigens: relevance in sperm-egg interaction and immunocontraception Soc Reprod Fertil 63 Suppl 2007 433 443
30. Simms M.S., Scholfield D.P., and Jacobs E. Anti-GnRH antibodies can induce castrate levels of testosterone in patients with advanced prostate cancer Br J Cancer 83 2000 443 446
31. Yu L., Zhang Z.F., Jing C.X., and Wu F.L. Intraperitoneal administration of gonadotropin-releasing hormone-PE40 induces castration in male rats World J Gastroenterol 14 2008 2106 2109
32. Bian Z.H., Zhang J., and Ding X.L. Localization of epididymal protease inhibitor in adult rat and its transcription profile in testis during postnatal development Asian J Androl 11 2009 731 739
33. Richardson R.T., Sivashanmugam P., and Hall S.H. Cloning and sequencing of human eppin: a novel family of protease inhibitors expressed in the epididymis and testis Gene 270 2001 93 102
34. Wang Z., Widgren E.E., Richardson R.T., and O'Rand M.G. Characterization of an eppin protein complex from human semen and spermatozoa Biol Reprod 77 2007 476 484
35. O'Rand M.G., Widgren E.E., Beyler S., and Richardson R.T. Inhibition of human sperm motility by contraceptive anti-eppin antibodies from infertile male monkeys: effect on cyclic adenosine monophosphate Biol Reprod 80 2009 279 285
36. O'Rand M.G., Widgren E.E., and Sivashanmugam P. Reversible immunocontraception in male monkeys immunized with eppin Science 306 2004 1189 1190
37. O'Rand M.G., Widgren E.E., Wang Z., and Richardson R.T. Eppin: an epididymal protease inhibitor and a target for male contraception Soc Reprod Fertil 63 Suppl 2007 445 453
38. Wang Z., Widgren E.E., Sivashanmugam P., O'Rand M.G., and Richardson R.T. Association of eppin with semenogelin on human spermatozoa Biol Reprod 72 2005 1064 1070
39. Robert M., Gagnon C., and Semenogelin I. A coagulum forming, multifunctional seminal vesicle protein Cell Mol Life Sci 55 1999 944 960
40. O'Rand M.G., Widgren E.E., Wang Z., and Richardson R.T. Eppin: an effective target for male contraception Mol Cell Endocrinol 250 2006 157 162
41. Naz R.K. Vaccine for contraception targeting sperm Immunol Rev 171 1999 193 202
42. Naz R.K. Development of genetically engineered human sperm immunocontraceptives J Reprod Immunol 83 2009 145 150
43. 2+ channels in sperm function Cell Calcium 40 2006 241 252
44. Darszon A., Acevedo J.J., and Galindo B.E. Sperm channel diversity and functional multiplicity Reproduction 131 2006 977 988
45. Florman H.M., Arnoult C., Kazam I.G., Li C., and O'Toole C.M. A perspective on the control of mammalian fertilization by egg-activated ion channels in sperm: a tale of two channels Biol Reprod 59 1998 12 16
46. Jimenez-Gonzalez C., Michelangeli F., Harper C.V., Barratt C.L., and Publicover S.J. Calcium signalling in human spermatozoa: a specialized 'toolkit' of channels, transporters and stores Hum Reprod Update 12 2005 253 267
47. Lobley A., Pierron V., Reynolds L., Allen L., and Michalovich D. Identification of human and mouse CatSper3 and CatSper4 genes: characterization of a common interaction domain and evidence for expression in testis Reprod Biol Endocrinol 1 2003 53 67
48. Jin J.L., O'Doherty A.M., and Wang S. Catsper3 and Catsper4 encode two cation channel-like proteins exclusively expressed in the testis Biol Reprod 73 2005 1235 1242
49. Qi H., Moran M.M., and Navarro B. All four CatSper ion channel proteins are required for male fertility and sperm cell hyperactivated motility Proc Natl Acad Sci U S A 104 2007 1219 1223
50. Ren D., Navarro B., and Perez G. A sperm ion channel required for sperm motility and male fertility Nature 413 2001 603 609
51. Quill T.A., Ren D., Clapham D.E., and Garbers D.L. A voltage-gated ion channel expressed specifically in spermatozoa Proc Natl Acad Sci U S A 98 2001 12527 12531
52. Navarro B., Kirichok Y., Chung J.J., and Clapham D.E. Ion channels that control fertility in mammalian spermatozoa Int J Dev Biol 52 2008 607 613
53. Carlson A.E., Burnett L.A., and del Camino D. Pharmacological targeting of native CatSper channels reveals a required role in maintenance of sperm hyperactivation PLoS ONE 4 2009 e6844
54. Benoff S., Cooper G.W., and Hurley I. The effect of calcium ion channel blockers on sperm fertilization potential Fertil Steril 62 1994 606 617
55. Morakinyo A.O., Iranloye B.O., and Adegoke O.A. Anti-reproductive effect of calcium channel blockers on male rats Reprod Med Biol 8 2009 97 102
56. Hodel C., and Suter K. Reversible inhibition of spermatogenesis with an indenopyridine (20-438) Arch Toxicol 1 Suppl 1978 323 326
57. Cook C.E., Wani M.C., and Jump J.M. Structure-activity studies of 2,3,4,4a,5,9b-hexahydroindenol[1,2-c]pyridines as antispermatogenic agents for male contraception J Med Chem 38 1995 753 763
58. Cook C.E., Jump J.M., and Zhang P. Exceptionally potent antispermatogenic compounds from 8-halogenation of (4aRS,5SR,9bRS)-hexahydroindeno-[1,2-c] pyridines J Med Chem 40 1997 2111 2112
59. Hild S.A., Reel J.R., Dykstra M.J., Mann P.C., and Marshall G.R. Acute adverse effects of indenopyridine, CDB-4022, on the ultrastructure of Sertoli cells, spermatocytes and spermatids in rat testes: comparison to the known Sertoli cell toxicant, di-n-pentylphthalate (DPP) J Androl 28 2007 621 629
60. Hild S.A., Attardi B.J., and Reel J.R. The ability of a gonadotropin-releasing hormone antagonist, acyline, to prevent irreversible infertility induced by the indenopyridine, CDB-4022, in adult male rats: the role of testosterone Biol Reprod 71 2004 348 358
61. Hild S.A., Reel J.R., Larner J.M., and Blye R.P. Disruption of spermatogenesis and Sertoli cell structure and function by the indenopyridine CDB-4022 in rats Biol Reprod 65 2001 1771 1779
62. Hild S.A., Meistrich M.L., Blye R.P., and Reel J.R. Lupron depot prevention of antispermatogenic/antifertility activity of the indenopyridine, CDB-4022, in the rat Biol Reprod 65 2001 165 172
63. Hild S.A., Marshall G.R., and Attardi B.J. Development of l-CDB-4022 as a nonsteroidal male oral contraceptive: induction and recovery from severe oligospermia in the adult male cynomolgus monkey (Macaca fascicularis) Endocrinology 148 2007 1784 1796
64. Chen Y.C., Cochrum R.K., and Tseng M.T. Effects of CDB-4022 on Leydig cell function in adult male rats Biol Reprod 149 2007 1850 1860
65. Koduri S., Hild S.A., Pessaint L., Reel J.R., and Attardi B.J. Mechanism of action of l-CDB-4022, a potential nonhormonal male contraceptive, in the seminiferous epithelium of the rat testis Endocrinology 2008 10.1210/en.2007-1332 (Pubitemid 351468361)
66. Davis R.J. The mitogen-activated protein kinase signal transduction pathway J Biol Chem 268 1993 14553 14556
67. Cobb M.H., and Goldsmith E.J. How MAP kinases are regulated J Biol Chem 270 1995 14843 14846
68. Seger R., and Krebs E.G. The MAPK signaling cascade FASEB J 9 1995 726 735
69. Kyriakis J.M., and Avruch J. Mammalian mitogen-activated protein kinase signal transduction pathways activated by stress and inflammation Physiol Rev 81 2001 807 869
70. Floridi A., Paggi M.G., and Marcante M.L. Lonidamine, a selective inhibitor of aerobic glycolysis of murine tumor cells J Natl Cancer Res 66 1981 497 499
71. Floridi A., Paggi M.G., and D'Atri S. Effect of lonidamine on the energy metabolism of Ehrlich ascites tumor cells Cancer Res 41 1981 4661 4666 (Pubitemid 12201388)
72. Zhou H.Y., Hu G.X., and Hu L.F. Adjudin targeting dog germ cell adhesion as a male contraceptive 2008 American Society for Andrology Annual Meeting Albuquerque (NM) (Abstract)
73. Lui W.Y., Lee W.M., and Cheng C.Y. Sertoli-germ cell adherens junction dynamics in the testis are regulated by RhoB GTPase via the ROCK/LIMK signaling pathway Biol Reprod 68 2003 2189 2206
74. Su L., Cheng C.Y., and Mruk D.D. Drug transporter, P-glycoprotein (MDR1), is an integrated component of the mammalian blood-testis barrier Int J Biochem Cell Biol 41 2009 2578 2587
75. Coulston F., Dougherty W.J., LeFevre R., Abraham R., and Silvestrini B. Reversible inhibition of spermatogenesis in rats and monkeys with a new class of indazole-carboxylic acids Exp Mol Pathol 23 1975 357 366
76. De Martino C., Malcorni W., Bellocci M., Floridi A., and Marcante M.L. Effects of AF1312 TS and lonidamine on mammalian testis. A morphological study Chemotherapy 27 Suppl 2 1981 27 42
77. Tash J.S., Chakrasali R., and Jakkaraj S.R. Gamendazole, an orally active indazole carboxylic acid male contraceptive agent, targets HSP90AB1 (HSP90BETA) and EEF1A1 (eFF1A), and stimulates Il1a transcription in rat Sertoli cells Biol Reprod 78 2008 1139 1152
78. Tash J.S., Attardi B.J., and Hild S.A. A novel potent indazole carboxylic acid derivative blocks spermatogenesis and is contraceptive in rats after a single oral dose Biol Reprod 78 2008 1127 1138
79. Dinarello C.A. Immunological and inflammatory functions of the interleukin-1 family Annu Rev Immunol 27 2009 519 550
80. Pasparakis M. Regulation of tissue homeostasis by NF-kB signalling: implications for inflammatory diseases Nat Rev Immunol 9 2009 778 788
81. California Agency Environmental Protection Summary of toxicological data: hydramethylnon 2000 Department of Pesticide Regulation, Medical Toxicology Branch Sacramento (CA) Available at: http://www.calepa.ca.gov
82. M.A. Kamrin, Pesticide profiles: toxicity, environmental impact, and fate 1997 CRC/Lewis Publishing Boca Raton (FL) 589 629
83. United States Agency Environmental Protection. Integrated Risk Information System Database. Washington, DC; 1995: 10-14. (http://www.epa.gov/ NCEA/iris )
84. Hellwig J., Deckardt K., and Freisberg K.O. Subchronic and chronic studies of the effects of oral administration of acrylic acid to rats Food Chem Toxicol 1993 1993 1 18
85. Pelicano H., Martin D.S., Xu R.H., and Huang P. Glycolysis inhibition for anticancer treatment Oncogene 25 2006 4633 4646
86. De Lena M., Lorusso V., and Latorre A. Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study Eur J Cancer 37 2001 364 368
87. Di Cosimo S., Ferretti G., and Papaldo P. Lonidamine: efficacy and safety in clinical trials for the treatment of solid tumors Drugs Today (Barc) 39 2003 157 174